Senior Business Executive, Independent
Kevin Reilly is a senior business executive with more than 30 years’ experience in the pharmaceutical and vaccine industries. During his 20 years with Wyeth Pharmaceuticals, he served in several positions covering responsibilities in Canada, Asia, and the Pacific region. From 1999 until his retirement in 2003, he was president of Wyeth’s $2 billion Vaccine and Nutrition Division. Prior to joining Wyeth, he spent ten years with Connaught Laboratories, a major vaccine manufacturer, in positions of increasing responsibility, including three years as executive vice president from 1980 to 1983. Mr. Reilly currently serves on the boards of Vaxgen Inc. and The Sabin Vaccine Institute and on the management committee for the Accelerated Development and Introduction Plans of the GAVI Alliance. Mr. Reilly is a native of Australia. He earned his Master of Business Administration from York University in Toronto, Canada, and is also a graduate of the Advanced Management Program of Harvard Business School.